Why is that at the exact same dose, with the exact same peptide that the weight loss differs for people with type 2 diabetes as compared to those who have pure obesity
En su momento tambin liraglutida haba salido al mercado solo como tratamiento de la diabetes en una dosis de hasta 1.8 mg y despus fue aprobada la dosis para obesidad (3mg)
J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A
When tirzepatide binds to these receptors, it enhances glucose-dependent insulin secretion from pancreatic beta cells, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying
Genetic variants affecting GLP-1 and GIP receptor function can influence how efficiently tirzepatide reduces inflammation and promotes weight loss in your body
Still need help